Our Pipeline

DIVERSE PIPELINE OF FIRST-IN-CLASS AESTHETIC AND DERMATOLOGICAL SOLUTIONS

Veradermics has cultivated a differentiated pipeline of multiple novel product candidates for large-market conditions seen in adults and children that are overdue for new treatment approaches.

PROGRAM INDICATION

MOA Delivery

PRE-IND

PHASE 1

PHASE 2

PHASE 3

MARKET

VDPHL

Androgenetic Alopecia

Confidential MOA

Oral Tablet

Phase 2/3 Ongoing - Males and Females

VDMN

Common Warts

Candida Antigen Extract

Immunotherapy

Dissolvable Microarray

Phase 2b Ongoing

VDAA

Alopecia Areata

Topical
Contact
Immunotherapy

Phase 2 Ready

VDMC
Molluscum Contagiosum

Topical

New Chemical Entity

Antiviral

IND Filed

VDAD

Atopic Dermatitis

Novel

New Chemical Entity
Oral Immunomodulator

Preclinical

ANDROGENETIC ALOPECIA